STEPHANIE WALKER: Open Payments
NPI 1235911066 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 33 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $109 |
| Lilly USA, LLC | 4 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $95 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $58 |
| Exact Sciences Corporation | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Amgen Inc. | 2 | $29 |
| Novo Nordisk Inc | 1 | $21 |
Products named: MOUNJARO, CAPLYTA, QULIPTA, Auvelity, JARDIANCE, XIFAXAN, Cologuard Collection Kit, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
